Samuel Shames is listed as an executive officer and director on 4 SEC Form D filings by 1 issuer between Jan 2015 and Oct 2024: Embr Labs Inc. (Boston, MA — other technology — 2015–2024; $5.97M reported sold to 11 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside David Kim (3 shared filings), Elizabeth Gazda (3 shared filings), Matthew J. Smith (3 shared filings), Bruce E Clarke (2 shared filings), David Cohen-Tanugi (2 shared filings) and 5 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Samuel. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Samuel Shames and found 4 differences: Samuel Shames's role changed at Embr Labs Inc.: executive officer, director → executive officer; 4 offerings have no amendment in the last 12 months and may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.